期刊文献+

双氯芬酸钠缓释制剂的释放度比较 被引量:2

暂未订购
导出
摘要 目的:考察不同药厂双氯芬酸钠制剂的释放度,评价其内在质量。方法:按《中国药典》2000版释放度测定法,以磷酸缓冲液为释放介质,采用转篮法,用反相高效液相色谱法测定释放液含量,进而计算其累积释放百分率并提取释放参数。结果:普通肠溶片释放最快,24.5min即释放85%以上,双释放控释片及双释放胶囊12 h累积释放百分率均为80%以上。结论:三个厂家的双氯芬酸钠制剂均符合《中国药典》2000版规定。
出处 《中国药师》 CAS 2003年第11期716-717,共2页 China Pharmacist
  • 相关文献

参考文献1

共引文献5

同被引文献15

  • 1邱贞琴.双氯芬酸钠缓释胶囊体外释放度考察[J].药学实践杂志,2001,19(1):21-22. 被引量:1
  • 2易涛,易以木.洛伐他汀缓释片的体外释放度和生物利用度[J].中国医院药学杂志,2004,24(8):458-460. 被引量:4
  • 3张春燕,刘家强,王洪光.双氯芬酸钠缓释片的制备和体外释放度研究[J].中国新药杂志,2005,14(8):1017-1019. 被引量:7
  • 4陈华,南楠,赵慧芳.骨架型芬太尼透皮贴剂释放度测定[J].药物分析杂志,2006,26(8):1068-1070. 被引量:7
  • 5ChP(中国药典).2000.Vol Ⅰ.2002.Supplement(增补):34.
  • 6U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) . Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms [Z]. 1997.
  • 7U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) . Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System [Z] . 1997.
  • 8U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) . Guidance for Industry: SUPAC-IR/MR: Immediate Release and Modified Release Solid Oral Dosage Forms [Z] . 1997.
  • 9Nilufer Yuksel, Arzu E. Kanik, Tamer Baykara. Comparison of in vitro dissolution profiles by ANOVA-based, model- dependent and independent methods [J]. International Journal of Pharmaceutics, 2000, (209): 57-67.
  • 10JAMES E. POLLI, G. SINGH REKHI, VINOD P. SHAH. Methods to compare dissolution profiles [J].Drug Information Journal, 1996, (30): 1113-1120.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部